Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Clin Geriatr Med. 2013 Nov;29(4):809–828. doi: 10.1016/j.cger.2013.07.006

Table 3.

Limitations of Biomarkers for AD

1. Majority of studies performed in select research populations
2. Lack of validation in autopsy studies
3. Lack of data for follow up past 1-2 years
4. Difficulty in collecting, processing and interpreting CSF biomarker data
5. Non-specificity of biomarkers
6. Precise temporal evolution of biomarkers not known